On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...